Inhibitory Antibodies
-
F2084 Anti-VEGFR1/FLT1 Antibody (Icrucumab)Summary: Anti-VEGFR1/FLT1 Antibody (Icrucumab) -
F2085 Anti-VEGF Antibody (Ranibizumab)Summary: Anti-VEGF Antibody (Ranibizumab) -
F2086 Anti-VEGFR2/KDR/CD309 Antibody (Vulinacimab)Summary: Anti-VEGFR2/KDR/CD309 Antibody (Vulinacimab) -
F2087 Anti-SCFR/c-Kit/CD117 Antibody (Barzolvolimab)Summary: Anti-SCFR/c-Kit/CD117 Antibody (Barzolvolimab) -
F2088 Anti-PDGFRA/CD140a Antibody (Tovetumab)Summary: Anti-PDGFRA/CD140a Antibody (Tovetumab) -
F2089 Anti-IGF-1 Antibody (Xentuzumab)Summary: Anti-IGF-1 Antibody (Xentuzumab) -
F2090 Anti-ANG2 & VEGFA Antibody (Faricimab)Summary: Anti-ANG2 & VEGFA Antibody (Faricimab) -
F2091 Anti-ANG2 & VEGFA Antibody (Vanucizumab)Summary: Anti-ANG2 & VEGFA Antibody (Vanucizumab) -
F2092 Anti-Polyubiquitin Antibody (Genentech patent anti-Polyubiquitin)Summary: Anti-Polyubiquitin Antibody (Genentech patent anti-Polyubiquitin) -
F2093 Anti-TGF-β Receptor Antibody (Sotatercept)Summary: Anti-TGF-β Receptor Antibody (Sotatercept)